Please enable JavaScript in your browser.  Drug Information Portal National Library of Medicine
Home
 
       Home    Search Results
 
Drug Information Portal
By Name   By Category  
 

Back  Go back to previous page.

 Search Results

Drug Name:  Rituximab [USAN:INN:BAN]    [show more names]
Description:  A genetically engineered anti-CD20 antibody for the treatment of B-cell lymphoma.

NCI: A recombinant chimeric murine/human antibody directed against the CD20 antigen, a hydrophobic transmembrane protein located on normal pre-B and mature B lymphocytes. Following binding, rituximab triggers a host cytotoxic immune response against CD20-positive cells.(NCI Dictionary) 
Categories:   Antineoplastic Agents    [show more categories]



Back  Go back to previous page.

 
 
Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Oct 2014
USA.gov